SE9901658D0 - New formulation - Google Patents

New formulation

Info

Publication number
SE9901658D0
SE9901658D0 SE9901658A SE9901658A SE9901658D0 SE 9901658 D0 SE9901658 D0 SE 9901658D0 SE 9901658 A SE9901658 A SE 9901658A SE 9901658 A SE9901658 A SE 9901658A SE 9901658 D0 SE9901658 D0 SE 9901658D0
Authority
SE
Sweden
Prior art keywords
new formulation
edisylate
methylthiazole
chloroethyl
physical
Prior art date
Application number
SE9901658A
Other languages
English (en)
Swedish (sv)
Inventor
Karin Ellstroem
Ingrid Jaeppinen
Tomas Petersson-Norden
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9901658A priority Critical patent/SE9901658D0/xx
Publication of SE9901658D0 publication Critical patent/SE9901658D0/xx
Priority to TNTNSN00094A priority patent/TNSN00094A1/fr
Priority to AU47922/00A priority patent/AU4792200A/en
Priority to JP2000616779A priority patent/JP2002544164A/ja
Priority to EP00930026A priority patent/EP1178798A1/en
Priority to PCT/SE2000/000876 priority patent/WO2000067753A1/en
Priority to ARP000102193A priority patent/AR023873A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE9901658A 1999-05-06 1999-05-06 New formulation SE9901658D0 (sv)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE9901658A SE9901658D0 (sv) 1999-05-06 1999-05-06 New formulation
TNTNSN00094A TNSN00094A1 (fr) 1999-05-06 2000-05-03 Nouvelle composition
AU47922/00A AU4792200A (en) 1999-05-06 2000-05-04 Parenteral formulation of 5-(2-chloroethyl)-4-methylthiazole edisylate(clomethiazole edisylate)
JP2000616779A JP2002544164A (ja) 1999-05-06 2000-05-04 ５−（２−クロロエチル）−４−メチルチアゾールエジシレート（クロメチアゾールエジシレート）の非経口処方物
EP00930026A EP1178798A1 (en) 1999-05-06 2000-05-04 Parenteral formulation of 5-(2-chloroethyl)-4-methylthiazole edisylate(clomethiazole edisylate)
PCT/SE2000/000876 WO2000067753A1 (en) 1999-05-06 2000-05-04 Parenteral formulation of 5-(2-chloroethyl)-4-methylthiazole edisylate(clomethiazole edisylate)
ARP000102193A AR023873A1 (es) 1999-05-06 2000-05-05 Formulacion

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9901658A SE9901658D0 (sv) 1999-05-06 1999-05-06 New formulation

Publications (1)

Publication Number Publication Date
SE9901658D0 true SE9901658D0 (sv) 1999-05-06

Family

ID=20415507

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9901658A SE9901658D0 (sv) 1999-05-06 1999-05-06 New formulation

Country Status (7)

Country Link
EP (1) EP1178798A1 (ja)
JP (1) JP2002544164A (ja)
AR (1) AR023873A1 (ja)
AU (1) AU4792200A (ja)
SE (1) SE9901658D0 (ja)
TN (1) TNSN00094A1 (ja)
WO (1) WO2000067753A1 (ja)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK733888A (da) * 1988-01-12 1989-07-13 Fujisawa Pharmaceutical Co Stabiliseringsmiddel
IL91856A0 (en) * 1988-10-11 1990-06-10 Schiapparelli Salute Spa Pharmaceutical compositions comprising calcitonin for intranasal administration and a spray unit for the administration of the same
SE8900564D0 (sv) * 1989-02-17 1989-02-17 Astra Ab Novel medicinal use
SE9002659D0 (sv) * 1990-08-15 1990-08-15 Astra Ab New pharmaceutical formulations

Also Published As

Publication number Publication date
JP2002544164A (ja) 2002-12-24
AR023873A1 (es) 2002-09-04
EP1178798A1 (en) 2002-02-13
WO2000067753A1 (en) 2000-11-16
TNSN00094A1 (fr) 2002-05-30
AU4792200A (en) 2000-11-21

Similar Documents

Publication Publication Date Title
UY29041A1 (es) Derivados de amino-piperidina, su preparacion y su utilización en terapeutica
ECSP056111A (es) Derivados de 2-acilamino-4-feniltiazol, su preparación y aplicación en terapeutica
DE60012188D1 (de) Fungizide
BR0115605A (pt) Derivados de naftaleno
BR0112969A (pt) Método de utilização de dicetopiperazinas e composições contendo-as
WO2005020894A3 (en) Rifamycin analogs and uses thereof
ATE330038T1 (de) Nukleinsäure-biosensor
BR0107815A (pt) Derivados aminados de di-hidro-1,3,5-triazina e suas aplicações em terapêutica
UY29327A1 (es) Derivados de n-(heteroaril)- 1 h- indol-2-carboxamidas, su preparacion y su aplicacion en terapeutica
BR0209149A (pt) Ftalazinonas
MY133969A (en) Indoloquinazolinones
MX2007009655A (es) Inhibidores de la proteasa del vih.
WO2005108565A3 (en) Modified xylanase, methods of making and use thereof
RS51478B (sr) Upotreba bradikardijskih supstanci u lečenju miokardnih oboljenja povezanih sa hipertrofijom i nove kombinacije lekova
BR0213990A (pt) Derivados de piperazina tendo atividade antagonìstica de sst1
BR0208566A (pt) Derivados de beta-carbolina
BR0211903A (pt) Isoxazolopiridinonas
UA83266C2 (en) Oxazole derivatives of tetracyclines
BR0115996A (pt) Sulfamidotienopirimidinas
ATE449066T1 (de) Biguanidderivate
BR0113581A (pt) Derivados de aril-piperazinas e seu uso como psicofármacos
BR0108500A (pt) Arilpiperazinas e arilpiperidinas e seu uso como agentes inibidores de metaloproteinase
SE9901658D0 (sv) New formulation
DE60017374D1 (de) Antibakterielle mittel
TR200103694T2 (tr) Sabit ksilometazolin ve oksimetazolin çözeltisi